Prosecution Insights
Last updated: November 11, 2026
Application No. 19/201,014

ORTHOPEDIC INSTRUMENT CONNECTION MECHANISMS AND RELATED ASSEMBLIES AND SYSTEMS FOR PROVIDING PROVISIONAL FIXATION

Non-Final OA §112
Filed
May 07, 2025
Priority
May 08, 2024 — provisional 63/644,328
Examiner
PRONE, CHRISTOPHER D
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Microport Orthopedics Holdings Inc.
OA Round
1 (Non-Final)
65%
Grant Probability
Moderate
1-2
OA Rounds
2y 9m
Est. Remaining
84%
With Interview

Examiner Intelligence

Grants 65% of resolved cases
65%
Career Allowance Rate
537 granted / 827 resolved
-5.1% vs TC avg
Strong +19% interview lift
Without
With
+19.0%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
48 currently pending
Career history
882
Total Applications
across all art units

Statute-Specific Performance

§101
2.1%
-37.9% vs TC avg
§103
47.7%
+7.7% vs TC avg
§102
23.1%
-16.9% vs TC avg
§112
25.5%
-14.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 827 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority This application claims priority from provisional application 63/644328, filed 05/08/2024. Status of Claims Claims 1-10 are pending. Claims 11-19 have been cancelled. Information Disclosure Statement The Information Disclosure Statements filed on 05/13/25, 09/17/25, and 01/29/26 have been considered by the examiner. Drawings The drawings are objected to under 37 CFR 1.83(a). The drawings must show every feature of the invention specified in the claims. Therefore, all of the different first medical device inserter configurations of claim 4, medical device implant configurations of claim 5, and the concave area of claims 2 and 3 (see 112 rejection for more details) must be shown or the feature(s) canceled from the claim(s). No new matter should be entered. Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-10 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 1 and 3 both define the movable non-rigid spacer as engaging “a pore of the plurality of pores” which renders the claims indefinite. [0044] defines the size of the pores as being in the range of micrometers but it is clear from the figures that the spacer is dramatically larger than a single pore. Therefore it is unclear how the spacer can be received by the single pore. A person of ordinary skill in the art would not be able to determine the scope of this phrase based on the original disclosure and figures. This is not considered new matter because the recitations are within the original claims. The applicant is advised to amend the claims to define the spacer as engaging a plurality of pores or to say it engages the porous inner surface. Claim 2 is rendered indefinite by the requirement for the second body to “closely receive” the first body. A person of ordinary skill in the art would be unable to determine the scope of this phrase. Does it require contact? Does it permit a gap? How big of a gap would still be considered close? Close is a relative term and some would say every component of the device is close to ever other component because they are all part of the same device. The applicant is advised to amend the claim to delete the term closely or provide specific clarification as to the scope of the term. Claim 3 is rendered indefinite for the same “closely” language as claim 2. The applicant is advised to amend the claim to delete the term closely or provide specific clarification as to the scope of the term. Claims 2 and 3 are further rendered indefinite by the requirement for the porous inner surface to define a “concave area”. The original disclosure defines 41 as the concave area which is best shown in Figure 3. However this surface has a round tapered shape not concave. A concave shape is generally understood within the art as being bowl shaped not just curved. Additionally is it unclear what the bottom of the porous surface is like because it is not shown as part of the inner exposed surface within the arched opening of Figure 3 and there is no other figure showing the shape specifically. Figure 5 shows a cutaway but has no reference to number 41. The applicant is advised to amend the claims to say rounded or curved surface in place of concave. Claim 10 is rendered indefinite by the recitation of “permutations”. A person of ordinary skill in the art would be unable to determine the scope of this term. Merriam Webster defines permutations as having major or fundamental changes based on some existing elements. It appears that this would allow almost any shape because major changes to the list of shapes would include any conical shape as well as shapes that are changed to no longer be conical. The claim is also rendered indefinite by options “components of any of the foregoing” and “components of trials of any of the foregoing”. Components would also allow for every known shape because any arbitrary or desired portions could be called components. Therefore the claim is rendered indefinite because the scope of these terms include every known shape. The applicant is advised to delete these three options. Additionally it is noted that including trials does not further limit the claim because any implant can be considered a trial implant. Allowable Subject Matter Claims 1-10 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. The prior art of record fails to disclose or render obvious the device comprising two nesting/conical medical devices, wherein the first medical device includes a spacer recess extending into the body and communicating with the outer surface including a movable non-rigid spacer, most prior art are rigid tabs or rings not the spring ball detent like structures and do not extend into the body, and the second medical device having a porous inner surface with a complementary shape that abuts the outer surface of the first medical device and has a pore for receiving the spacer. The most relevant prior art is references 2013/0079785, 2008/0161811 (Figure 9), 2006/0241781, 2004/0220673, and 2002/0072799. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHRISTOPHER D PRONE whose telephone number is (571)272-6085. The examiner can normally be reached Monday-Friday 10 am - 6 pm (HST). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Melanie R Tyson can be reached at (571)272-9062. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. CHRISTOPHER D. PRONE Primary Examiner Art Unit 3774 /Christopher D. Prone/Primary Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

May 07, 2025
Application Filed
Oct 30, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12765996
PROSTHETIC HEMI HEART VALVE
5y 6m to grant Granted Oct 20, 2026
Patent 12758389
KNEE JOINT ENDOPROSTHESIS SET AND INSTRUMENTS
5y 4m to grant Granted Oct 13, 2026
Patent 12758396
ORTHOPAEDIC SURGICAL SYSTEM FOR INSTALLING A KNEE CONE AUGMENT AND METHOD OF USING THE SAME
4y 8m to grant Granted Oct 13, 2026
Patent 12751843
BIFURCATED DUAL-BALLOON CATHETER SYSTEM FOR BIFURCATED VESSELS
4y 11m to grant Granted Oct 06, 2026
Patent 12751810
GENDER-SPECIFIC MESH IMPLANT WITH BARRIER FOR INGUINAL HERNIA REPAIR
4y 9m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
84%
With Interview (+19.0%)
4y 3m (~2y 9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 827 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month